2 sprays of 15 ml

sprays symptomatic treatment of the oral cavity and ENT organs: gingivitis, glossitis, stomatitis pharyngitis, laryngitis

Indications:
Symptomatic treatment of pain syndrome of inflammatory diseases of the oral cavity and ENT organs (of various etiologies): - gingivitis, glossitis, stomatitis (including after radiation and chemotherapy); - pharyngitis, laryngitis, tonsillitis; - candidiasis of the oral mucosa (as part of combination therapy); - calculous inflammation of the salivary glands; - after surgical interventions and injuries (tonsillectomy, jaw fractures) - after treatment and tooth extraction; - periodontal disease; For infectious and inflammatory diseases requiring systemic treatment, it is necessary to use it as part of combination therapy.

Description:
Asterisk ENT is a topical spray that was developed taking into account the needs of people suffering from acute respiratory viral infections and colds. The drug has a disinfectant, analgesic and anti-inflammatory effect, which helps to quickly relieve symptoms of the disease, such as gingivitis, glossitis, stomatitis (including after radiation and chemotherapy); - pharyngitis, laryngitis, tonsillitis. A convenient spray bottle allows you to easily and quickly use the drug anywhere - at work, at home or on the road. Just one press of the spray dispenser will help you cope with the first symptoms of the disease and return to your daily activities in the shortest possible time.

Compound:
Active ingredient - benzydamine hydrochloride - 45 mg;
Auxiliary components: glycerol (glycerin) - 1500 mg; ethanol 96% - 2540 mg; sodium saccharinate - 7.5 mg, macrogol glyceryl hydroxystearate - 37.5 mg; sodium hydroxide - 0.014 mg; mint flavor AAL-4313 (propylene glycol 63.8%, natural flavor extract 15.8%, esters 10.7%, ethers 0.4%, hydroxy compounds 9.0%, ketones and lactones 0.3%) - 15 mg; purified water up to 15 ml.

IndicationsSymptomatic treatment of pain syndrome of inflammatory diseases of the oral cavity and ENT organs (of various etiologies

- gingivitis, glossitis, stomatitis (including after radiation and chemotherapy);
- pharyngitis, laryngitis, tonsillitis;
- candidiasis of the oral mucosa (as part of combination therapy);
- calculous inflammation of the salivary glands;
- after surgical interventions and injuries (tonsillectomy, jaw fractures)
- after treatment and tooth extraction;
- periodontal disease;
For infectious and inflammatory diseases requiring systemic treatment, it is necessary to use it as part of combination therapy.

Hypersensitivity to benzydamine or other components of the drug, children under 3 years of age (for topical spray 0.15%) or children under 18 years of age (for topical spray 0.30%).
Carefully:

Hypersensitivity to acetylsalicylic acid or other non-steroidal anti-inflammatory drugs, bronchial asthma (including a history); alcoholism, high-risk patients, including those with liver disease and eplepsy, traumatic brain injury, brain diseases.